Suppr超能文献

一个基于机器学习的针对老年心血管疾病患者潜在不适当处方的风险预警平台。

A machine learning-based risk warning platform for potentially inappropriate prescriptions for elderly patients with cardiovascular disease.

作者信息

Xingwei Wu, Huan Chang, Mengting Li, Lv Qin, Jiaying Zhang, Enwu Long, Jiuqun Zhu, Rongsheng Tong

机构信息

Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.

Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, Sichuan, China.

出版信息

Front Pharmacol. 2022 Aug 11;13:804566. doi: 10.3389/fphar.2022.804566. eCollection 2022.

Abstract

Potentially inappropriate prescribing (PIP), including potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs), is a major risk factor for adverse drug reactions (ADRs). Establishing a risk warning model for PIP to screen high-risk patients and implementing targeted interventions would significantly reduce the occurrence of PIP and adverse drug events. Elderly patients with cardiovascular disease hospitalized at the Sichuan Provincial People's Hospital were included in the study. Information about PIP, PIM, and PPO was obtained by reviewing patient prescriptions according to the STOPP/START criteria (2nd edition). Data were divided into a training set and test set at a ratio of 8:2. Five sampling methods, three feature screening methods, and eighteen machine learning algorithms were used to handle data and establish risk warning models. A 10-fold cross-validation method was employed for internal validation in the training set, and the bootstrap method was used for external validation in the test set. The performances were assessed by area under the receiver operating characteristic curve (AUC), and the risk warning platform was developed based on the best models. The contributions of features were interpreted using SHapley Additive ExPlanation (SHAP). A total of 404 patients were included in the study (318 [78.7%] with PIP; 112 [27.7%] with PIM; and 273 [67.6%] with PPO). After data sampling and feature selection, 15 datasets were obtained and 270 risk warning models were built based on them to predict PIP, PPO, and PIM, respectively. External validation showed that the AUCs of the best model for PIP, PPO, and PIM were 0.8341, 0.7007, and 0.7061, respectively. The results suggested that angina, number of medications, number of diseases, and age were the key factors in the PIP risk warning model. The risk warning platform was established to predict PIP, PIM, and PPO, which has acceptable accuracy, prediction performance, and potential clinical application perspective.

摘要

潜在不适当处方(PIP),包括潜在不适当药物(PIM)和潜在处方遗漏(PPO),是药物不良反应(ADR)的主要风险因素。建立PIP风险预警模型以筛查高危患者并实施针对性干预措施,将显著减少PIP和不良药物事件的发生。纳入了在四川省人民医院住院的老年心血管疾病患者进行研究。根据STOPP/START标准(第2版)审查患者处方,获取有关PIP、PIM和PPO的信息。数据按8:2的比例分为训练集和测试集。使用五种抽样方法、三种特征筛选方法和十八种机器学习算法来处理数据并建立风险预警模型。在训练集中采用10折交叉验证方法进行内部验证,在测试集中采用自助法进行外部验证。通过受试者操作特征曲线下面积(AUC)评估模型性能,并基于最佳模型开发风险预警平台。使用SHapley加法解释(SHAP)来解释特征的贡献。该研究共纳入404例患者(318例[78.7%]存在PIP;112例[27.7%]存在PIM;273例[67.6%]存在PPO)。经过数据抽样和特征选择后,获得了15个数据集,并基于这些数据集建立了270个风险预警模型,分别用于预测PIP、PPO和PIM。外部验证表明,PIP、PPO和PIM最佳模型的AUC分别为0.8341、0.7007和0.7061。结果表明,心绞痛、用药数量、疾病数量和年龄是PIP风险预警模型的关键因素。建立了用于预测PIP、PIM和PPO的风险预警平台,其具有可接受的准确性、预测性能和潜在的临床应用前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d12f/9402906/5d3e08cd5381/fphar-13-804566-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验